The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Neuraceq
Florbetaben F 18 · FLORBETABEN F-18 135 mCi/mL · Injection, Solution · Intravenous · Lantheus Biosciences Ltd., a Lantheus company
NDC 54828-0001-50 · 1 VIAL, MULTI-DOSE in 1 CONTAINER / 50 mL in 1 VIAL, MULTI-DOSE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Medicaid spend (2025)
$12,072
22 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA204677
- TE code
- —
- Approval date
- Mar 19, 2014
- Patents / exclusivity
- 2 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 9308284 | Jul 14, 2032 |
| patent | 7807135 | Mar 18, 2029 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class II · TerminatedAug 22, 2023Sofie Co dba Sofie — Lack of Assurance of Sterility: out-of-specification test results observed for Filter Integrity Test (FIT).
Manufacturers of Florbetaben F 18 (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Lantheus Biosciences Ltd., a Lantheus company | FLORBETABEN F-18 135 mCi/mL | Jul 29, 2026 | Sep 2, 2026 |
| Lantheus Biosciences Ltd., a Lantheus Company | FLORBETABEN F-18 135 mCi/mL | Jul 15, 2026 | Jul 22, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Neuraceq — NDC 54828-0001-50," retrieved September 3, 2026, https://drugdashboards.com/drug/54828000150.
Free to cite with attribution — see how the data is put together.